Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 36,414	$ 21,456
Marketable securities	12,511	5,726
Trade accounts receivable, net	5,215	5,813
Other current assets	3,802	4,085
Total current assets	57,942	37,080
Property and equipment, net	1,445	1,570
Intangibles, net	26,720	28,458
Goodwill	8,576	8,641
Lease right of use assets	3,930	4,017
Other assets	1,106	786
Total assets	99,719	80,552
Current liabilities:
Accounts payable and other accrued liabilities	4,100	6,672
Deferred revenue, current	5,256	5,853
Total current liabilities	9,356	12,525
Long-term lease liabilities	5,812	5,994
Other long-term liabilities	80	106
Total liabilities	15,248	18,625
Commitments and contingencies (Note 15)
Shareholders’ equity:
Preferred stock (par value $0.001 per share, 2,500 authorized, 10 shares issued and outstanding at March 31, 2024 and December 31, 2023)	50	50
Common stock (par value $0.001 per share, 50,000 authorized, 21,372 and 20,379 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively)	21	20
Additional paid-in capital	409,473	376,189
Accumulated deficit	(322,106)	(311,768)
Accumulated other comprehensive loss	(2,967)	(2,564)
Total shareholders’ equity	84,471	61,927
Total liabilities and shareholders’ equity	$ 99,719	$ 80,552